The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 330:786-787 March 17, 1994 Number 11
NextNext

Retinoblastoma Gene Mutations in Human Cancer

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
The retinoblastoma gene (RB) was identified because of germ-line mutations that strongly predisposed infants with the mutant gene to a rare cancer of the retina. However, the RB protein turned out to be a regulator of transcription in all cells of adults. The active form of the protein represses the expression of genes required for cells to proceed through the cycle of cell division. Phosphorylation, mediated by a complex of several proteins regulated by the cell cycle (a cyclin and a cyclin-dependent kinase), inactivates the RB protein, allowing cell division to begin.

It is easy to understand that mutations resulting . . . [Full Text of this Article]

Recommended Reading


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.